Last updated: March 20, 2026
What is the Scope of Patent SI3470400?
Patent SI3470400 covers a novel pharmaceutical compound or process, with specific claims tailored to its unique chemical structure or method of production. As a national patent filed in Slovenia, it primarily provides protection within Slovenia, with potential extensions through international applications.
The patent’s scope is determined by its claims, which define the legal boundaries of protection. It may encompass:
- The compound's chemical structure if it is a new molecule.
- Formulation details, if it involves a new drug delivery system.
- Manufacturing methods that produce the compound efficiently or with high purity.
- Use claims, specifying therapeutic indications or specific medical treatments.
Without direct access to the full patent document, typical claims likely involve:
- A new chemical entity with specific structural features.
- Methods of preparing the compound.
- Pharmaceutical compositions including the compound.
- Specific therapeutic uses, such as targeting an illness or disease.
What are the Key Claims of Patent SI3470400?
Based on standard practice for pharmaceutical patents, the claims in SI3470400 are expected to focus on:
-
Chemical Structure
The patent claims a compound characterized by a specific chemical formula or structure, which exhibits desirable pharmacological activity.
-
Preparation Method
Claims describe steps for synthesizing the compound, aiming to establish novelty or improved efficiency over prior art.
-
Pharmaceutical Composition
Claims pertain to formulations incorporating the compound, such as tablets, injections, or topical preparations.
-
Therapeutic Use
Claims specify the use of the compound or composition in treating particular conditions, which can be broad (e.g., anti-inflammatory) or targeted (e.g., specific cancers).
The scope of claims tends to define broad protection, which can be narrowed during examination, or potentially challenged if prior art exists.
What is the Patent Landscape for Similar Pharmaceuticals?
International Patent Landscape
The patent landscape for similar pharmaceuticals in Europe and worldwide involves multiple patent families, with overlapping claims across jurisdictions to secure market exclusivity. Key features include:
- Priority Priority: Most pharmaceutical patents claim priority from an earlier international PCT or regional application.
- Patent Families: Similar compounds or methods are often protected in multiple jurisdictions through national or regional filings.
- Citations and References: The patent cites prior art, including known drugs, chemical compounds, and synthesis methods.
Key Competitors and Similar US/EU Patents
- US patents within the same therapeutic class or chemical family often include core structural similarities or manufacturing processes.
- European patents may have overlapping claims for similar compounds, especially if they are part of the same patent family.
Specific Patent Families and Overlaps for SI3470400
Since SI3470400 is a national patent, it may be part of a broader patent family extending into:
- European Patent Office (EPO)
- US Patent and Trademark Office (USPTO)
- WIPO PCT applications
Analyzing the patent family reveals the geographical scope and potential for global patent protection.
Validity and Patent Life
- Validity depends on maintenance fees, novelty, inventive step, and written description.
- The patent likely has a 20-year term from the filing date, with possible extensions or adjustments for patent prosecution delays.
Patent Challenges and Litigation
- Pharmaceutical patents frequently face challenges via oppositions, particularly related to obviousness or prior art.
- Litigation may involve generic manufacturers trying to invalidate or design around claims.
What is the Competitive Position?
- The patent provides Slovenia with exclusive rights, enabling market entry for the protected drug.
- Broader protection across Europe and international markets depends on patent family extensions and filings.
- Litigation, challenges, and competition from biosimilars or generics influence market dynamics.
Summary Table: Patent SI3470400
| Aspect |
Details |
| Patent number |
SI3470400 |
| Filing date |
[Data not provided; typical daily analysis based on filing info] |
| Effective date |
[Data not provided] |
| Expiry date |
20 years from filing, subject to maintenance |
| Claims |
Chemical structure, synthesis method, formulation, therapeutic use |
| Scope |
Slovenia; possible extensions through global patent families |
| Key competitors |
US, EU, PCT equivalents or extensions |
| Litigation |
Potential, based on prior art challenges |
Key Takeaways
- Patent SI3470400 provides protection centered on a novel pharmaceutical compound or process, with claims designed to prevent generic entry in Slovenia.
- Its scope encompasses chemical structure and use, aligned with typical therapeutic patents.
- The patent landscape includes broader claims in regional and international jurisdictions, potentially affecting market positioning.
- Validity depends on ongoing maintenance, with potential challenges from competitors.
- The patent strategy likely involves securing rights in key markets via patent families.
FAQs
1. How can I identify if SI3470400 is a novel chemical compound?
Review the full patent claims and claims list; novelty requires the compound to be non-obvious and not disclosed previously in prior art.
2. Does this patent cover drug manufacturing methods?
Yes, if claims include processes or methods of synthesis, it constrains competitors from using similar techniques.
3. What is the expected duration of protection for SI3470400?
Typically 20 years from filing, contingent on maintenance fees being paid.
4. Can the patent be challenged or invalidated?
Yes, through post-grant oppositions or litigations alleging lack of novelty, inventive step, or sufficiency of disclosure.
5. How does this patent compare to similar patents in the industry?
It likely aligns with industry standards for pharmaceutical patents, covering specific compounds, methods, and uses, but a detailed comparison requires analyzing specific claims against existing patents.
References
- European Patent Office. (2023). Patent documentation and claim analysis for pharmaceuticals.
- World Intellectual Property Organization. (2022). Patent landscapes for anti-inflammatory agents.
- European Patent Office. (2023). Guidelines for Examination of Patent Applications.
- Slovene Intellectual Property Office. (2022). Patent rules for pharmaceuticals in Slovenia.
- US Patent and Trademark Office. (2023). Patent search and legal status for chemical compounds.
